头颈癌多学科综合诊疗模式与生存期的关联:一项回顾性队列研究
该回顾性队列研究纳入3081例I-IVB期头颈癌患者(实施前1431例,实施后1650例),比较每周多学科门诊和病例讨论会实施前后的生存差异。实施后患者3年总生存率79.9% vs 实施前77.1%(P=0.07),疾病特异生存率87.5% vs 84.9%(P=0.05);调整后实施前患者总生存HR 1.20(95%CI 1.02-1.40)、疾病特异生存HR 1.26(95%CI 1.03-1.54),晚期肿瘤患者生存改善更明显。
要点
- 实施多学科门诊和病例讨论会后,头颈癌患者3年总生存率和疾病特异生存率数值上均高于实施前。
- 调整混杂因素后,实施前患者总生存HR 1.20(95%CI 1.02-1.40)、疾病特异生存HR 1.26(95%CI 1.03-1.54)。
- 未调整和调整分析中,晚期肿瘤患者的生存改善均更明显。
核心结论
- 多学科门诊和病例讨论会与头颈癌患者预后改善相关,尤其是晚期肿瘤患者。
研究设计与样本
- 回顾性队列研究,纳入3081例I-IVB期口腔、口咽、下咽、鼻咽或喉部肿瘤患者,其中实施前1431例、实施后1650例。
- 比较每周多学科门诊和病例讨论会实施前后诊断后1年、2年、3年总生存和疾病特异生存差异。
- 采用未调整Kaplan-Meier曲线和多变量Cox比例风险回归模型,调整人口学特征、合并症负担、吸烟状态、肿瘤部位和分期、口咽鳞癌p16状态及初始治疗方式。
主要发现
- 实施前患者较实施后更少表现为口咽鳞癌和晚期肿瘤(III-IVB期),更少接受单纯手术或手术联合辅助治疗作为初始治疗。
- 实施前和实施的3年总生存率分别为77.1%和79.9%(P=0.07),3年疾病特异生存率分别为84.9%和87.5%(P=0.05)。
- 3年时,实施前患者调整后总生存(HR 1.20;95%CI 1.02-1.40)和疾病特异生存(HR 1.26;95%CI 1.03-1.54)略差于实施后患者。
- 在未调整和调整分析中,晚期肿瘤患者的生存改善更明显。
临床怎么用
- 作者认为,所有头颈癌患者均应接受多学科团队管理,尤其是晚期肿瘤患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare survival among patients with head and neck cancer before and after implementing a weekly multidisciplinary clinic and case conference. METHODS: A retrospective cohort study with chart review was conducted of 3081 patients (1431 preimplementation, 1650 postimplementation) diagnosed with stage I-IVB tumors in the oral cavity, oropharynx, hypopharynx, nasopharynx, or larynx. Pre- and postimplementation differences in overall and disease-specific survival 1, 2, and 3 years after diagnosis were assessed with unadjusted Kaplan-Meier curves and multivariable Cox proportional hazard regression models adjusted for demographic characteristics, comorbidity burden, smoking status, tumor site and stage, p16 status for oropharyngeal squamous cell cancer, and initial treatment modality. RESULTS: Patients less commonly presented with oropharyngeal squamous cell cancer and advanced tumors (III-IVB) and received primary treatment with surgery alone or with adjuvant therapy preimplementation than postimplementation. Overall survival at 3 years was 77.1% and 79.9% (P = .07) and disease-specific survival was 84.9% and 87.5% (P = .05) among pre- and postimplementation patients, respectively. At 3 years, preimplementation patients had slightly poorer overall (hazard ratio, 1.20; 95% CI, 1.02-1.40) and disease-specific (hazard ratio, 1.26; 95% CI, 1.03-1.54) adjusted survival than postimplementation patients. In unadjusted and adjusted analyses, survival improvements were more pronounced among patients with advanced disease. DISCUSSION: A multidisciplinary clinic and case conference were associated with improved outcomes among patients with head and neck cancer, especially those with advanced tumors. IMPLICATIONS FOR PRACTICE: All patients with head and neck cancer should receive multidisciplinary team management, especially those with advanced tumors.
引用
- Meltzer C, Nguyen NT, Zhang J, et al. Survival Associated With Consolidated Multidisciplinary Care in Head and Neck Cancer: A Retrospective Cohort Study. Otolaryngol Head Neck Surg. 2023. PMID: 34752163. doi:10.1177/01945998211057852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。